SCHEMBL23501191

SCHEMBL23501191

Cn1cc(-c2cc(O)c3c(NC(=O)c4ccccc4)cnn3c2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.46
RET P07949 4/20 0.46
CSF1R P07333 2/20 0.43
KIT P10721 2/20 0.43
WNT1 P04628 3/20 0.41
GSK3B P49841 3/20 0.41
DYRK1A Q13627 3/20 0.41
AURKB Q96GD4 2/20 0.41
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
AURKA O14965 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
PIK3CG P48736 1/20 0.41
KCNMA1 Q12791 1/20 0.41
HDAC2 Q92769 1/20 0.41
TTK P33981 1/20 0.41
CLK2 P49760 1/20 0.41
CLK3 P49761 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23501262 0.86 CSF1R (0.47) HDAC1RETCSF1RKITAURKB
SCHEMBL23501127 0.84 PIK3CG (0.51) RETPIK3CGTTK
SCHEMBL23501444 0.82 MAP4K1 (0.42) RETAURKBPIK3CG
SCHEMBL23501304 0.81 PIK3CG (0.38) RETWNT1GSK3BDYRK1AIRAK4
SCHEMBL23501195 0.81 CSF1R (0.43) HDAC1RETCSF1RKITAURKB
SCHEMBL23501214 0.80 DYRK1A (0.51) RETWNT1GSK3BDYRK1A
SCHEMBL23501220 0.75 CLK1 (0.46) RETPIK3CG
SCHEMBL23501280 0.72 RET (0.43) RETPIK3CG
SCHEMBL23501179 0.72 RET (0.44) RET
SCHEMBL18390079 0.72 RET (0.52) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112939967-B Pyrazolo [1,5-a ] pyridine compound, and preparation method and application thereof 深圳众格生物科技有限公司 2024-08-27 CN disclosed
CN-114787161-B Pyrazolo [1,5-a ] pyridine compound, and preparation method and application thereof 深圳众格生物科技有限公司 2024-08-02 CN disclosed
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-07-13 US disclosed
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-07-13 US disclosed
EP-4074710-A1 PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shenzhen Zhongge Biological Technology Co., Ltd (CN) 2022-10-19 EP disclosed
CN-114787161-A Pyrazolo [1,5-a ] pyridine compound and preparation method and application thereof 深圳众格生物科技有限公司 2022-07-22 CN disclosed
WO-2021115457-A9 PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 深圳众格生物科技有限公司 2022-05-19 WO disclosed
WO-2021115457-A1 PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 深圳晶泰科技有限公司 2021-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF RET, GRK4, RIN1 HDAC1 1880/4885RET 1/4885CSF1R 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.